← FDA Drug Approvals (Drugs@FDA)

INLURIYO

NDA · New Drug Application · Sponsor: ELI LILLY AND CO · Approved 2025-09-25

Drug application

FDA Application #

NDA218881

Application type

New Drug Application

Brand name

INLURIYO

Generic name

IMLUNESTRANT

Active ingredients

IMLUNESTRANT TOSYLATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ELI LILLY AND CO

Manufacturer

Eli Lilly and Company

First approval

2025-09-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown